BIOS

BioPlus Acquisition Corp. Class A Ordinary Shares

Delisted

BIOS was delisted on the 6th of October, 2023.

56 hedge funds and large institutions have $173M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$99K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$15.2M
2 +$11.7M
3 +$9.88M
4
Millennium Management
Millennium Management
New York
+$9.78M
5
Goldman Sachs
Goldman Sachs
New York
+$8.15M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
51
$205K
52
$198K
53
$99K
54
$22K
55
$2K
56
$205